查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
Favipiravir的全球市场(2022年～2028年)
市场调查报告书
商品编码
1215699

Favipiravir的全球市场(2022年～2028年)

Favipiravir Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3个工作天内

价格

全球Favipiravir的市场规模，在预测期间内预计以4.1％的年复合成长率大幅成长。

由于以流感A/B，伊波拉，COVID-19，其他疾病为标的新药的持续性开发，对市场成长有效贡献的主要企业的存在，促进全球Favipiravir市场成长。还有抗病毒药物Favipiravir的製造、销售相关法规当局的认证高涨，也成为促进市场成长的要素。

本报告提供全球Favipiravir市场相关调查分析，市场概要，各市场区隔、地区的市场分析，竞争情形，企业简介等系统性资讯。

目录

第1章 报告概要

第2章 市场概要与洞察

  • 调查范围
  • 分析师的洞察和目前市场趋势

第3章 竞争情形

  • 主要企业分析
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的开发
  • 主要策略分析

第4章 市场决策要素

  • 促进因素
  • 阻碍因素
  • 机会

第5章 市场明细

  • 全球Favipiravir市场:各用途
    • 流感A/B
    • 伊波拉
    • COVID-19
    • 其他
  • 全球Favipiravir市场:各流通管道
    • 医院、诊所
    • 药妆店、药局
    • 线上

第6章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 其他地区
    • 南美
    • 中东、非洲

第7章 企业简介

  • Beacon Pharmaceuticals. Ltd.
  • ChemRar Group
  • Cipla. Ltd.
  • Dr. Reddy's Laboratories. Ltd.
  • Fujifilm Toyoma Chemicals Co. Ltd.
  • Glenmark Pharmaceuticals. Ltd.
  • Lupin Healthcare. Ltd.
  • R-Pharma
  • Sun Pharmaceutical Industries. Ltd.
  • Zhejiang Hisun Pharmaceutical Co. Ltd
Product Code: OMR2026755

Title:Global Favipiravir Market Size, Share and Trends Analysis Report, By Application (Influenza A&B, Ebola, COVID-19, and Others), By Distribution Channel (Hospitals & Clinics, Drug Stores/Pharmacies, and Online) Forecast Period (2022-2028).

The global favipiravir market is anticipated to grow at a substantial CAGR of 4.1% during the forecast period. The global favipiravir market growth is driven by the presence of major players that are contributing effectively to the growth of the market by continuous development of new drugs targeting Influenza A&B, Ebola, COVID-19, and other diseases. The rising regulatory approvals for the manufacturing and marketing of antiviral drug favipiravir is also the factor driving the market growth. For instance, in July 2020, Cipla Ltd. Received approval for the launch of the anti-viral drug favipiravir in India under the brand name 'Ciplenza' for the treatment of COVID-19 patients. The drug has been jointly developed by Cipla and CSIR-Indian Institute of Chemical Technology (IICT). Similarly, in June 2020, India-based Glenmark Pharmaceuticals got approval for the manufacturing and marketing of favipiravir under the brand name FabiFlu to treat mild to moderate COVID-19.

The global favipiravir market is segmented based on application and distribution channels. Based on application, the market is sub-segmented into Influenza A&B, Ebola, COVID-19, and others. Among these, the use of favipiravir in COVID-19 disease treatment is expected to increase more during the forecast period, thereby driving segment growth. Ongoing R&D and clinical trials for the efficacy of favipiravir in the treatment of COVID-19 will drive segment growth. Similarly, based on distribution channels, the market is sub-segmented into hospitals & clinics, drug stores/pharmacies, and online.

Geographically, the favipiravir market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe is projected to witness notable growth in the market during the forecast period. The increasing prevalence of Ebola in Europe is increasing the demand for favipiravir. The increased approval of the favipiravir drug has positively affected regional market growth. In November 2019, the European Commission granted marketing authorization to Merck's vaccine, known as Ervebo for Ebola. The vaccine was designed at Canada's National Microbiology Laboratory with funding from the U.S. government's Biomedical Advanced Research and Development Authority, for the protection against the Zaire species of Ebola.

The major market players in the global favipiravir market include Fujifilm Toyoma Chemicals Co. Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd., and Dr. Reddy's Laboratories Ltd., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in July 2020, Dr. Reddy's Laboratories Ltd. Collaborated with Fujifilm to launch the innovator brand of favipiravir "Avigan" in India. The partnership accelerated the company's development, manufacture, and sales of Avigan tablets.

Research Methodology

The market study of the global favipiravir market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Favipiravir Market Research and Analysis by Application
  • Global Favipiravir Market Research and Analysis by Distribution Channel

The Report Covers:

  • Comprehensive research methodology of the global favipiravir market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global favipiravir market.
  • Insights about market determinants that are stimulating the global favipiravir market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Favipiravir Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Favipiravir Market by Application
    • 5.1.1. Influenza A&B
    • 5.1.2. Ebola
    • 5.1.3. COVID-19
    • 5.1.4. Others
  • 5.2. Global Favipiravir Market by Distribution Channel
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Drug Stores/Pharmacies
    • 5.2.3. Online

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East & Africa

7. Company Profiles

  • 7.1. Beacon Pharmaceuticals. Ltd.
  • 7.2. ChemRar Group
  • 7.3. Cipla. Ltd.
  • 7.4. Dr. Reddy's Laboratories. Ltd.
  • 7.5. Fujifilm Toyoma Chemicals Co. Ltd.
  • 7.6. Glenmark Pharmaceuticals. Ltd.
  • 7.7. Lupin Healthcare. Ltd.
  • 7.8. R-Pharma
  • 7.9. Sun Pharmaceutical Industries. Ltd.
  • 7.10. Zhejiang Hisun Pharmaceutical Co. Ltd

LIST OF TABLES

  • 1. GLOBAL FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 2. GLOBAL FAVIPIRAVIR IN INFLUENZA A&B MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL FAVIPIRAVIR IN EBOLA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL FAVIPIRAVIR IN COVID-19 MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL FAVIPIRAVIR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 7. GLOBAL FAVIPIRAVIR IN HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL FAVIPIRAVIR IN DRUG STORES/PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL FAVIPIRAVIR IN ONLINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. NORTH AMERICAN FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 14. EUROPEAN FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 15. EUROPEAN FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 16. EUROPEAN FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 17. ASIA-PACIFIC FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 20. REST OF THE WORLD FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD FAVIPIRAVIR MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL FAVIPIRAVIR MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 2. GLOBAL FAVIPIRAVIR MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
  • 3. GLOBAL FAVIPIRAVIR MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 4. GLOBAL FAVIPIRAVIR IN INFLUENZA A&B MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL FAVIPIRAVIR IN EBOLA MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL FAVIPIRAVIR IN COVID-19 MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL FAVIPIRAVIR OTHER APPLICATIONS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL FAVIPIRAVIR IN HOSPITALS & CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 9. GLOBAL FAVIPIRAVIR IN DRUG STORES/PHARMACIES MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 10. GLOBAL FAVIPIRAVIR IN ONLINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 11. US FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. CANADA FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 13. UK FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. FRANCE FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. GERMANY FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. ITALY FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. SPAIN FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. REST OF EUROPE FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. INDIA FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. CHINA FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. JAPAN FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. SOUTH KOREA FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. REST OF THE WORLD FAVIPIRAVIR MARKET SIZE, 2021-2028 ($ MILLION)